var singsData = [{"date":new Date(2012,1,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,1,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,10,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Overweight. Target Price is $19; previously $20.","showOnAxis":false},{"date":new Date(2012,10,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2012,10,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,10,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, DNR reports 2012 Q3's earning $0.33 per share and revenue $579.4MM. This meets analyst's estimated EPS $0.33, misses estimated revenue $602.97MM.","showOnAxis":false},{"date":new Date(2012,10,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,11,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,2,1),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Sterne Agee upgrades DNR to Neutral from Underperform.","showOnAxis":false},{"date":new Date(2012,2,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,3,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,3,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,4,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,4,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2012,4,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,4,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,4,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,4,3),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, DNR reports 2012 Q1's earning $0.29 per share and revenue $640.296MM..","showOnAxis":false},{"date":new Date(2012,5,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,5,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,5,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,5,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,6,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Overweight. Target Price is $20; previously $23.","showOnAxis":false},{"date":new Date(2012,6,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains DNR to Overweight. Target Price is $25; previously $23.5.","showOnAxis":false},{"date":new Date(2012,6,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"ISI Group terminates DNR coverage .","showOnAxis":false},{"date":new Date(2012,7,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,7,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,7,2),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, DNR reports 2012 Q2's earning $0.35 per share  This beats analyst's estimated EPS $0.34.","showOnAxis":false},{"date":new Date(2012,8,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,8,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,8,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,8,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,8,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,8,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains DNR to Buy. Target Price is $22; previously $18.","showOnAxis":false},{"date":new Date(2012,8,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse initiates coverage on DNR to Neutral. Target Price is $18.5.","showOnAxis":false},{"date":new Date(2012,8,7),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Sterne Agee upgrades DNR to Buy from Neutral. Target Price is $20.","showOnAxis":false},{"date":new Date(2012,9,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Susquehanna upgrades DNR to Positive from Neutral.","showOnAxis":false},{"date":new Date(2013,0,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2013,0,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,0,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,0,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains DNR to Buy. Target Price is $24; previously $22.","showOnAxis":false},{"date":new Date(2013,0,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2013,0,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Overweight. Target Price is $21; previously $19.","showOnAxis":false},{"date":new Date(2013,1,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,21),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, DNR reports 2012 Q4's earning $0.36 per share and revenue $609.2MM. This beats analyst's estimated EPS $0.29, beats estimated revenue $568.5MM.","showOnAxis":false},{"date":new Date(2013,1,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains DNR to Neutral. Target Price is $18; previously $17.","showOnAxis":false},{"date":new Date(2013,1,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,10,13),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Raymond James downgrades DNR to Market Perform from Outperform; previously $24.","showOnAxis":false},{"date":new Date(2013,10,25),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Susquehanna downgrades DNR to Neutral from Positive. Target Price is $19; previously $23.","showOnAxis":false},{"date":new Date(2013,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, DNR reports 2013 Q3's earning $0.45 per share and revenue $674MM. This beats analyst's estimated EPS $0.43, beats estimated revenue $666.42MM.","showOnAxis":false},{"date":new Date(2013,10,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,10,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,10,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,11,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,11,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains DNR to Neutral. Target Price is $17.9; previously $18.","showOnAxis":false},{"date":new Date(2013,2,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,2,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,4,2),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, DNR reports 2013 Q1's earning $0.23 per share and revenue $580.211MM..","showOnAxis":false},{"date":new Date(2013,4,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,4,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,4,29),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Credit Suisse upgrades DNR to Outperform from Neutral. Target Price is $24; previously $20.","showOnAxis":false},{"date":new Date(2013,5,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,5,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital initiates coverage on DNR to Market Perform. Target Price is $18.","showOnAxis":false},{"date":new Date(2013,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, DNR reports 2013 Q2's earning $0.41 per share and revenue $645MM. This beats analyst's estimated EPS $0.35, beats estimated revenue $635.69MM.","showOnAxis":false},{"date":new Date(2013,8,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs initiates coverage on DNR to Neutral. Target Price is $19.","showOnAxis":false},{"date":new Date(2013,8,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Scotia Howard Weil initiates coverage on DNR.","showOnAxis":false},{"date":new Date(2014,0,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,0,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,0,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,0,30),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Goldman Sachs downgrades DNR to Sell from Neutral. Target Price is $17.","showOnAxis":false},{"date":new Date(2014,1,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains DNR to Buy. Target Price is $21; previously $25.","showOnAxis":false},{"date":new Date(2014,1,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2014,10,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,10,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,10,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,17),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Credit Suisse downgrades DNR to Neutral from Outperform. Target Price is $16; previously $19.","showOnAxis":false},{"date":new Date(2014,10,17),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Sterne Agee downgrades DNR to Neutral from Buy. Target Price is $18.","showOnAxis":false},{"date":new Date(2014,10,19),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Wunderlich downgrades DNR to Hold from Buy. Target Price is $11; previously $22.","showOnAxis":false},{"date":new Date(2014,10,20),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Barclays downgrades DNR to Equal-weight from Overweight. Target Price is $11; previously $15.","showOnAxis":false},{"date":new Date(2014,10,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,10,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2014,10,28),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Ladenburg Thalmann downgrades DNR to Neutral from Buy. Target Price is $10; previously $16.","showOnAxis":false},{"date":new Date(2014,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,10,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Overweight. Target Price is $15; previously $18.","showOnAxis":false},{"date":new Date(2014,11,15),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"KLR Group upgrades DNR to Buy from Accumulate. Target Price is $13.","showOnAxis":false},{"date":new Date(2014,11,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Equal-Weight. Target Price is $8; previously $11.","showOnAxis":false},{"date":new Date(2014,11,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,11,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,11,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2014,3,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,3,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,3,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,3,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Overweight. Target Price is $20; previously $21.","showOnAxis":false},{"date":new Date(2014,3,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,3,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,3,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,3,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2014,3,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,4,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,4,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2014,4,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains DNR to Overweight. Target Price is $21; previously $21.5.","showOnAxis":false},{"date":new Date(2014,4,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,6,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Overweight. Target Price is $24; previously $20.","showOnAxis":false},{"date":new Date(2014,6,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,7,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,7,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains DNR to Neutral. Target Price is $18; previously $19.","showOnAxis":false},{"date":new Date(2014,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains DNR to Neutral. Target Price is $17.6; previously $17.9.","showOnAxis":false},{"date":new Date(2014,8,18),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"RBC Capital downgrades DNR to Sector Perform from Outperform. Target Price is $19; previously $20.","showOnAxis":false},{"date":new Date(2014,9,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains DNR to Buy. Target Price is $22; previously $24.","showOnAxis":false},{"date":new Date(2014,9,27),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades DNR to Hold from Buy; previously $18.","showOnAxis":false},{"date":new Date(2014,9,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,9,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Overweight. Target Price is $18; previously $24.","showOnAxis":false},{"date":new Date(2014,9,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"KeyBanc maintains DNR to Buy. Target Price is $20; previously $23.","showOnAxis":false},{"date":new Date(2015,0,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Equal-Weight. Target Price is $5; previously $8.","showOnAxis":false},{"date":new Date(2015,0,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,0,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,1,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,1,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2015,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,11,18),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades DNR to Sell from Hold.","showOnAxis":false},{"date":new Date(2015,11,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,11,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,11,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,2,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,3,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs initiates coverage on DNR to Sell. Target Price is $6.","showOnAxis":false},{"date":new Date(2015,3,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura initiates coverage on DNR to Reduce. Target Price is $9.","showOnAxis":false},{"date":new Date(2015,3,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,4,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,4,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,4,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2015,4,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,5,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Equal-Weight. Target Price is $6; previously $5.","showOnAxis":false},{"date":new Date(2015,6,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cowen & Co. initiates coverage on DNR to Outperform. Target Price is $9.","showOnAxis":false},{"date":new Date(2015,6,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cowen & Co. initiates coverage on DNR to Outperform. Target Price is $9.","showOnAxis":false},{"date":new Date(2015,6,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"KeyBanc maintains DNR to Overweight. Target Price is $7; previously $11.","showOnAxis":false},{"date":new Date(2015,6,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse assumes DNR to Neutral. Target Price is $6; previously $10.","showOnAxis":false},{"date":new Date(2015,6,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,7,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.063","showOnAxis":true},{"date":new Date(2015,7,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,7,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,8,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,8,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,8,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,8,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,8,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,8,8),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Cowen & Co. downgrades DNR to Market Perform from Outperform. Target Price is $3; previously $6.","showOnAxis":false},{"date":new Date(2015,8,8),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Credit Suisse downgrades DNR to Underperform from Neutral. Target Price is $1; previously $6.","showOnAxis":false},{"date":new Date(2015,9,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains DNR to Sell. Target Price is $2; previously $3.","showOnAxis":false},{"date":new Date(2016,0,11),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Cowen & Co. upgrades DNR to Market Perform from Underperform.","showOnAxis":false},{"date":new Date(2016,0,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,0,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,0,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,0,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,0,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains DNR. Target Price is $1; previously $4.","showOnAxis":false},{"date":new Date(2016,0,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Equal-Weight. Target Price is $2; previously $4.","showOnAxis":false},{"date":new Date(2016,0,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains DNR to Equal-Weight. Target Price is $2; previously $4.","showOnAxis":false},{"date":new Date(2016,0,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,0,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,0,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,1,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,1,18),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, DNR reports 2015 Q4's earning $-0.01 per share and revenue $269.617MM. This misses analyst's estimated EPS $0.01, misses estimated revenue $339.84MM.","showOnAxis":false},{"date":new Date(2016,1,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Johnson Rice downgrades DNR to Hold from Accumulate.","showOnAxis":false},{"date":new Date(2016,1,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital maintains DNR to Sector Perform. Target Price is $1.5; previously $2.5.","showOnAxis":false},{"date":new Date(2016,1,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,1,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2016,10,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,10,3),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, DNR reports 2016 Q3's earning $0 per share and revenue $253.985MM. This beats analyst's estimated EPS $-0.02, beats estimated revenue $245.6MM.","showOnAxis":false},{"date":new Date(2016,2,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,2,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,3,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,3,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,3,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2016,3,26),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"KeyBanc initiates coverage on DNR to Sector Perform.","showOnAxis":false},{"date":new Date(2016,4,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,4,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2016,4,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Unregistered Sales of Equity Securities\r\n","showOnAxis":true},{"date":new Date(2016,4,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2016,4,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,4,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Unregistered Sales of Equity Securities\r\n","showOnAxis":true},{"date":new Date(2016,4,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,4,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,4,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,4,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,4,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Unregistered Sales of Equity Securities\r\n","showOnAxis":true},{"date":new Date(2016,4,5),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, DNR reports 2016 Q1's earning $-0.03 per share and revenue $194.844MM. This beats analyst's estimated EPS $-0.07, misses estimated revenue $274.69MM.","showOnAxis":false},{"date":new Date(2016,5,15),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades DNR to Hold from Sell.","showOnAxis":false},{"date":new Date(2016,5,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,5,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,7,10),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Barclays downgrades DNR to Underweight from Equal-Weight. Target Price is $2.5; previously $3.","showOnAxis":false},{"date":new Date(2016,7,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,7,4),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, DNR reports 2016 Q2's earning $0.08 per share and revenue $255.148MM. This beats analyst's estimated EPS $0.02, misses estimated revenue $284.01MM.","showOnAxis":false},{"date":new Date(2016,9,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,9,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true}];